Zentek 和 Medwell 結盟，利用 ZenGUARD™ 增強型外科口罩徹底改變醫療保健

Zentek Ltd. 和 Medwell Solutions LLC 已簽署了一份在美國經銷 ZenGUARD 增強型外科口罩的最終經銷協議。該協議自 2024 年 3 月 18 日起生效，有效期為 FDA 市場批准後的兩年。 Medwell Solutions 是一家總部位於達拉斯的製造商和分銷商，專門生產醫療保健產品，並因其在該領域的品質和經驗而受到認可。 Zentek 的 ZenGUARD 技術提高了口罩的病毒過濾效率，此次合作符合 Zentek 擴大市場覆蓋範圍的目標。

Zentek and Medwell Forge a Strategic Alliance to Revolutionize the U.S. Healthcare Industry with ZenGUARD™ Enhanced Surgical Masks

Zentek 和 Medwell 結成策略聯盟，利用 ZenGUARD™ 增強型外科口罩徹底改變美國醫療保健產業

GUELPH, ONTARIO, CANADA – March 18, 2024 – Zentek Ltd. (TSX: ZTEK), a trailblazing intellectual property development and commercialization enterprise, proudly announces a groundbreaking distribution agreement with Medwell Solutions LLC, a renowned Dallas-based healthcare product distributor. This partnership will propel the distribution of Zentek's revolutionary ZenGUARD™ Enhanced Surgical Masks throughout the vast healthcare landscape of the United States. Effective March 18, 2024, this two-year agreement will commence upon FDA market clearance.

加拿大安大略省圭爾夫– 2024 年3 月18 日– 開創性知識產權開發和商業化企業Zentek Ltd.（多倫多證券交易所股票代碼：ZTEK）自豪地宣布與達拉斯著名醫療保健產品分銷商Medwell Solutions LLC達成突破性分銷協議。此次合作將推動 Zentek 革命性的 ZenGUARD™ 增強型外科口罩在美國廣大醫療保健領域的分銷。該為期兩年的協議將於 FDA 市場批准後開始生效，自 2024 年 3 月 18 日起生效。

A Synergy of Expertise: Empowering Healthcare Professionals

專業知識的協同作用：賦予醫療保健專業人員權力

Medwell Solutions, a pillar of the healthcare industry, has established an unparalleled reputation for delivering exceptional products and services to healthcare facilities. Their comprehensive portfolio encompasses surgical devices, patient care supplies, and other essential consumables. With a proven track record spanning over two decades, Medwell's leadership has garnered extensive expertise in surgical technology and hospital supply chain management.

Medwell Solutions 是醫療保健行業的支柱，在為醫療保健機構提供卓越的產品和服務方面建立了無與倫比的聲譽。他們全面的產品組合包括手術設備、病患護理用品和其他基本消耗品。憑藉著二十多年的良好業績記錄，梅德韋爾的領導能力在外科技術和醫院供應鏈管理方面積累了廣泛的專業知識。

Zentek, the visionary behind ZenGUARD™ technology, has engineered a breakthrough solution to enhance the efficacy of face masks and HVAC systems in filtering viruses. Their state-of-the-art production facility in Guelph, Ontario, has earned ISO 13485:2016 certification, a testament to their unwavering commitment to medical device quality management systems.

ZenGUARD™ 技術背後的遠見者 Zentek 設計了一個突破性的解決方案，以增強口罩和 HVAC 系統過濾病毒的功效。他們位於安大略省圭爾夫市的最先進的生產設施已獲得 ISO 13485:2016 認證，證明了他們對醫療器材品質管理系統的堅定承諾。

Market Expansion and Supplier Diversity

市場擴張和供應商多元化

This strategic partnership aligns seamlessly with Zentek's overarching goal of expanding its market reach. By leveraging Medwell's extensive distribution network and diverse supplier certifications, Zentek aims to make ZenGUARD™ masks readily accessible to healthcare professionals across the nation.

這項策略夥伴關係與 Zentek 擴大市場覆蓋範圍的整體目標完美契合。透過利用 Medwell 廣泛的分銷網絡和多元化的供應商認證，Zentek 的目標是讓全國的醫療保健專業人員可以輕鬆獲得 ZenGUARD™ 口罩。

Executive Perspectives: A Shared Vision

高階主管視角：共同願景

Greg Fenton, CEO of Zentek, expressed unwavering confidence in the potential of this partnership: "Medwell's established sales channels and deep understanding of the healthcare market make them an ideal partner for the distribution of ZenGUARD™ masks. We are confident that their expertise will enable us to reach a broader audience and make a significant impact on the lives of healthcare professionals."

Zentek 執行長Greg Fenton 對此合作的潛力表達了堅定的信心：「Medwell 成熟的銷售管道和對醫療保健市場的深入了解使他們成為ZenGUARD™ 口罩分銷的理想合作夥伴。我們相信，他們的專業知識將使我們將覆蓋更廣泛的受眾並對醫療保健專業人員的生活產生重大影響。”

Keith J. Palmer, CEO of Medwell, echoed this enthusiasm: "We are thrilled to partner with Zentek and introduce ZenGUARD™ masks to the U.S. healthcare market. Their innovative technology aligns perfectly with our mission of providing cutting-edge solutions to healthcare providers. We believe that ZenGUARD™ masks have the potential to transform the industry, enhancing protection and improving patient outcomes."

Medwell 執行長Keith J. Palmer 也表達了這種熱情：「我們很高興與Zentek 合作，將ZenGUARD™ 口罩引入美國醫療保健市場。他們的創新技術與我們為醫療保健提供者提供尖端解決方案的使命完美契合。我們相信 ZenGUARD™ 口罩有潛力改變行業，增強保護並改善患者的治療效果。”

Financial Insights: Assessing Zentek's Market Position

財務洞察：評估 Zentek 的市場地位

As Zentek embarks on this pivotal distribution agreement, investors and industry observers are closely scrutinizing the company's financial health and market performance.

隨著 Zentek 著手簽署這項關鍵分銷協議，投資者和行業觀察家正在密切關注該公司的財務狀況和市場表現。

• Market Capitalization (Adjusted): As of today, Zentek's market capitalization stands at $120.39 million USD.
• P/E Ratio (Adjusted): The company's price-to-earnings ratio, based on the last twelve months leading up to Q3 2024, is currently -13.79, indicating that it is not currently generating profits.
• Revenue Growth: Over the same period, Zentek has experienced a significant decline in revenue, with a -85.06% change as of Q3 2024.

InvestingPro Tips: Unlocking Zentek's Potential

市值（調整後）：截至今日，Zentek 的市值為 1.2039 億美元。本益比（調整後）：該公司的本益比基於截至 2024 年第三季的過去 12 個月，目前為-13.79，顯示目前尚未產生利潤。營收成長：同期，Zentek 收入大幅下降，截至2024 年第三季度，變化為-85.06%。InvestingPro 提示：釋放Zentek 潛力

Analysts at InvestingPro, a leading financial insights platform, offer valuable insights into Zentek's market positioning and competitive edge:

領先的金融洞察平台 InvestingPro 的分析師對 Zentek 的市場定位和競爭優勢提供了寶貴的見解：

• Industry Niche Positioning: Zentek operates as a niche player in its industry, which could impact its ability to gain a substantial market share.
• Financial Stability: The company's liquid assets exceed its short-term obligations, providing a degree of financial stability in managing immediate responsibilities.
• Gross Profit Margins: Zentek's weak gross profit margins, reflected in a negative -841.52% over the last twelve months as of Q3 2024, could be a cause for concern.

Investors seeking a comprehensive analysis of Zentek's financial performance can explore InvestingPro's exclusive Tips at https://www.investing.com/pro/ZTEK. These insights encompass Zentek's debt levels, valuation multiples, and historical performance.

行業利基定位：Zentek 在其行業中作為利基參與者運營，這可能會影響其獲得大量市場份額的能力。財務穩定性：公司的流動資產超過其短期債務，在管理直接責任方面提供一定程度的財務穩定性毛利率：Zentek 的毛利率疲軟，截至2024 年第三季的過去12 個月為負-841.52%，可能會引起擔憂。尋求對Zentek 財務業績進行全面分析的投資者可以在以下網址探索InvestingPro 的獨家提示： https://www.investing.com/pro/ZTEK。這些見解包括 Zentek 的債務水準、估值倍數和歷史業績。

Exclusive Offer for Enhanced Insights

增強洞察力的獨家優惠

For investors seeking a deeper dive into Zentek's financial future, InvestingPro is offering an exclusive 10% off a yearly or biyearly Pro and Pro+ subscription with the coupon code PRONEWS24. This limited-time offer provides access to an enhanced toolset for making informed investment decisions.

對於尋求更深入了解 Zentek 財務未來的投資者，InvestingPro 提供每年或每兩年一次的 Pro 和 Pro+ 訂閱獨家 10% 折扣，優惠券代碼為 PRONEWS24。透過此限時優惠，您可以存取增強的工具集，以做出明智的投資決策。

Conclusion: A Transformative Partnership

結論：變革性的夥伴關係

The distribution agreement between Zentek and Medwell Solutions represents a pivotal moment for the healthcare industry. ZenGUARD™ Enhanced Surgical Masks, empowered by Zentek's innovative technology, are poised to revolutionize infection prevention practices, benefiting healthcare professionals and patients alike. This partnership will undoubtedly reshape the healthcare landscape, highlighting the power of collaboration in driving innovation and enhancing patient outcomes.

Zentek 和 Medwell Solutions 之間的分銷協議代表著醫療保健行業的關鍵時刻。 ZenGUARD™ 增強型外科口罩由 Zentek 的創新技術提供支持，有望徹底改變感染預防實踐，使醫療保健專業人員和患者受益。這種夥伴關係無疑將重塑醫療保健格局，凸顯合作在推動創新和改善病患治療效果的力量。